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Summary.-Breast-cancer tissue from 60 patients was tested for oestrogen and
testosterone sensitivity in vitro by measuring [3H]-dT incorporation in tissue
fragments at various times during 48h culture. Hormone sensitivity in test culture
was determined as an increase or decrease in dT uptake. In vitro cultures of breast-
cancer tissue demonstrate that some tumours are hormone-sensitive and others
hormone-insensitive, but it cannot be predicted whether cell proliferation is stimu-
lated or inhibited by hormone treatment.
The data were related to the clinical stage of the patients, menopausal status, and
the degree of anaplasia of the tumours tested. No correlation was observed between
these parameters and in vitro hormonal sensitivity. However, when related to the
response of patients to various kinds of hormonal treatment, a significant positive
correlation was obtained.
ONE THIRD OF PATIENTS with advanced
breast cancer respond to endocrine
therapy.
The oestrogen-receptor (RE) assay on
breast-cancer tissue has been used to
select patients for hormonal treatment,
but as present only half the patients with
RE+ tumours actually benefit from
endocrine therapy. It has been shown,
however, that tumours containing both
RE and progesterone receptors, and
tumours containing high RE levels, are
more likely to respond (70-80%) than
tumours with low RE levels or none
(5-10%; McGuire, 1980).
Instead of measuring the initial binding
step in the hormone action, another
approach would be to determine hormonal
influence on the tumours in vitro. It has
been shown that the in vitro effect of
hormones on breast-cancer tissue is not
simply a reflection of the presence or
absence of steroid receptors (Israel &
Saez, 1978; Poulsen, 1978; Sanfillipo et al.,
1979) and our proposed line of investiga-
tion might yield new information.
The purpose of this study was to
observe the effect of various hormones on
the [3H]-dT incorporation in breast-cancer
tissue in vitro, and to compare the results
with the effect of hormonal treatment on
patients with advanced breast cancer.
MATERIALS AND METHODS
In vitro technique.-Radioactive thymidine
[3H]-dT was obtained from The Radio-
chemical Centre, Amersham. Steroids were
obtained from Sigma Chemical Co., and
foetal calf serum from Flow Laboratories.
Insta-gel was obtained from Packard and K4
emulsion from Ilford.
Surgically excised breast-cancer tissue
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from 60 patients with primary breast cancer
were placed in ice-cold Eagle's minimal
essential medium (MEM) and prepared for
cultivation within 1 hofremoval. Alldamaged
and fatty tissue was removed, and the rest
was minced into small fragments (
- 0 5 mm3)
with a pair of scissors, all under sterile
conditions. With a spatula, 15-20 fragments
were then randomly transferred to 10 ml test
tubes containing 5 ml culture medium and
allowed to float freely. The medium was
MEM with added antibiotics (100 iu/ml of
penicillin and 100 ,ug/ml streptomycin) and
supplemented with foetal calf serum to a
concentration of 5%. Four cultures of 15-20
fragments each were set up for each hormone
and for control. All cultures were grown in an
atmosphere of 95% humidified air and 5%
C02 at 370C. The tissue fragments were
cultivated under the following conditions;
(1) controls, 0.1% ethanol added, (2) 17-p-
oestradiol, 1 juM, (3) testosterone, 1 ,aM.
The steroid hormones were dissolved in
ethanol, of which the final concentration
was 0-1% of the total volume in the culture
medium. They were added to the medium
when the cultures were set up.
At different times after explantation,
[3H]-dT was added to the cultures for 1 h
(2.5 ,uCi/ml, 2X0 Ci/mmol) and the incorpora-
tion was terminated by placing the cultures
on ice. The supernatant was removed and 5%
trichloroacetic acid added for 45 min. After
centrifugation (800 g, 40C) for 10 min, the
final sediment was dissolved in 2-0 ml 1 M
NaOH for 2 h at 60°C. Each sample was
divided into two portions. One portion
(200 ,ld) was prepared for scintillation count-
ing by mixing it with 12 ml scintillation
fluid (Insta-gel). Radioactivity was measured
in a Packard TriCarb 3003 spectrophoto-
meter. The quench was checked with channel
radio correction. The other portion (100 jAl)
was prepared for protein measurement by the
method of Lowry.
The results were expressed in terms of
ct/min/,ug protein. As the results may not be
normally distributed, the results of controls
and hormone-treated cultures were compared
by means of the nonparametric Mann-Whit-
ney test (Diem & Lentner, 1970). When the
results from the test-cultures were signifi-
cantly different from the control cultures
(P<0.05) the tumours were defined as
hormone-sensitive, the others hormone-
insensitive.
Histological procedure.-From all biopsy
specimens received, one representative piece
was taken at once for histological examina-
tion, and another 15-20 fragments randomly
selected from the cultures at the end of
cultivation.
Autoradiography.-Cultivated tissue frag-
ments were fixed and embedded in paraffin.
Three-4/tm sections were placed on gelatin-
izedslides and dipped into IlfordK4emulsion.
The autoradiographs were developed after
1-2 weeks' exposure in lightproof boxes at
40C. The developed slides were stained with
haematoxylin and eosin and evaluated for
localization of [3H1]-dTinthetissuefragments.
RESULTS
Histological and autoradiographic studies
The biopsy specimens received were all
confirmed as breast cancer. Examination
of the cultivated fragments showed that
the tissue was well preserved. In general,
necrobiosis was only slightly accentuated
during cultivation.
In most of the autoradiographs, the
background radiation was negligible. The
radioactivity was localized in the cell
nuclei. Apart from a few fibroblasts, all
labelled cells were epithelial. Cells with
pyknotic nuclei did notincorporate thymi-
dine.
Thymidine incorporation in cultures at
varying times after explantation
Preliminary experiments were carried
out to determine culture conditions, and
to determine whether specimens from the
same tumour showed comparable uptake
of [3H]-dT under the same conditions. It
was found in 4 tumours that samples
consisting of 4 cultures of 15-20 fragments
each were comparable, whether protein or
DNA content was used (Bonting & Jones,
1957) to estimate the amount of tissue.
Any differences in uptake of [3H]-dT
would thus be due to hormonal effect on
the tumour tissue.
Figs. 1-7 show the results from 7
different tumours. It appears that the dT
uptake varies markedly during cultiva-
tion, and is not due to varying protein
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cointent, which was fairly constant during
cultivation. It appears that a significant
hormonal effect (P < 0.05) could be re-
corded 18-24 h after addition of steroid
to some tumours (Nos. 3, 5, 6 & 7) and
that the steroid effect may occur as a
significant increase or decrease of dT
uptake in the same tumour, according to
the time of [3H]-dT addition (Nos. 3and 5).
The conclusion was that in vitro hormonal
sensitivity seems to manifest itself as
fluctuation in dT incorporation rate,
rather than in generally increased or
decreased rates. As it was found that the
hormonal effect, if any, could be recorded
consistently within 24 h of the cultures
being set up, the remaining 49 tumours
were only cultivated for that period. All
of them were exposed to oestrogen, and
11 (22%) were found to be oestrogen-
sensitive. The mean increase or decrease
in [3H]-dT uptake in these tumours varied
between 25 and 3050o (median 65%o)
compared to the corresponding mean
values of the control cultures. In 10/11
cases the difference was over 40%. The
corresponding features in the insensitive
group were 1-42%/ (median: 15%) and in
only one case was the difference over 400o.
Thirty-four tumours were also exposed
to testosterone, and 8 (23%) were sensi-
tive. The mean difference in [3H]-dT
uptake, compared to the mean values of
the controls, varied between 27 and 130%
(median 51%) and in 7/8 cases the
difference was more than 300g. The
variation of these features in the insenisi-
tive group was 2-37% (median 90o). In
25 cases the variation was below 300g.
Four tumours were sensitive to both
oestrogen and testosterone.
Hormonal sensitivity and various clinical
and pathological characteristics
It can be seen from Table I that no
correlation with menopausal status could
be found. Furthermore, no relation could
be found between the postmenopausal age
of the patients and hormone sensitivity
(Table II). From Table III it can be seen
that hormone sensitivity was not corre-
lated to clinical stage.
The infiltrating-duct carcinomas were
graded according to the method described
by Scharff & Torloni (1968) and, as seen
from Table IV, no significant difference in
oestrogen (2ca= 00 IO) or testosterone sensi-
tivity (2o= 020) could be found. Conse-
quently, patients with histologically un-
differentiated tumours (Grade 3) did not
differ in hormone sensitivity in vitro from
patients with well and moderately differ-
entiated tumours (Grades I and 2).
Hormonal sensitivity in vitro and patients'
response to endocrine therapy
The clinical response of the patients
with metastatic disease was evaluated.
Only patients with measurable disease
treated with hormones were evaluated.
Patients with 2 or more cancers were
excluded, as well as patients who were
TABLE I. Hormonal sensitivity of human breast-cancer tissue inl vitro and mtenopausal
.statu8
Oestrogen-senisitive/total
Testosterone-sensitive/total
AMenopausal status
Pre- Post-
2/9 9/40
1/7 7/27
Statistical evaluation
(Fishers exact test)
2c = -20 NS
2c = 0-20 NS
TI'ABLE II.-Hormonalsensitivityofhuman breast-cancertissue in vitr'o andpostmtenopausal
age
Oestrogeni-sensitive/total
Testosterone-sensitive/total
Postmenopausal age (years) Statistical
r~~ --evalulatioIn
1-10 10-15 15-20 >20 (X2)
/8 6/15 0/8 2/9 NS
1/6 5/11 05/ I/5 NS
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TABLE III.-Hormonal sensitivity of human breast-cancer tissue in vitro and TNM
clinical classification
Oestrogen-sensitive/tota.l
Testosterone-sensitive/total
TNM classification
1+11 III+IV
5/22 6/27
3/16 5/18
Statistical evaluation
(Fisher's exact test)
2ax = O - 20 NS
2a==0*20 NS
TABLE IV.-Hormonal sensitivity of human breast-cancer tissue in vitro and histological
grade of anaplasia (WHO)
Histological grade
1+11 III
Oestrogen-sensitive/total
Testosterone-sesnsitive/total
5/25
6/20
not followed up properly with X-ray and
clinical examinations. In total, 5 patients
out of 28 were excluded. Two patients
had 2 cancers, and in 3 cases the follow-up
was not evaluable.
The clinical trial was retrospective. The
patients were notgiven a specific hormonal
treatment based on a protocol, but
neither were the treatments influenced by
the results of the in vitro hormonal sensi-
tivity investigations. The criteria for
clinical response were defined as follows:
(1) CR-complete remission: total dis-
appearance of measurable disease.
(2) PR-partial remission: 50-99o re-
duction of measurable disease and/or
recalcification of osteolytic metastases.
No lesions showed progression and there
were no new lesions.
(3) SD-stationary disease: <50o re-
duction in measurable tumour mass and/or
no change in osteolytic bone metastases.
(4) PD-progression of measurable tu-
mour mass and/or appearance of new
lesions. Metastases showed no regression.
The duration of response was defined as
the time from initial treatment to pro-
gressive disease.
The characteristics of the patients are
shown in Table V. It can be seen that
several hormonal treatments have been
used. Premenopausal women were always
castrated by X-ray, which was occasion-
ally supplemented with other forms of
hormonal treatment (Pts 10, 15, 19, 20 &
23). Postmenopausal women were treated
2/14
2/11
Statistical evaluation
(Fisher's exact test)
2a=O* 10 NS
2oc= 0 * 20 NS
with tamoxifen (30 mg daily), prednisone
(15 mg daily) and diethylstilboestrol (1 mg
daily) either alone or in different combina-
tions. The doses of the drugs applied are
those normally given to this group of
patients.
The overall response rate was 26% (6/23,
see Tables V & VI). The median length
of remission was 13 months, range 6-24.
The disease-free interval did not differ
between patients with oestrogen-sensitive
tumours in vitro, and those with oestrogen-
insensitive tumours (15 months, range
3-46 VS 23 months, range 0-52).
A significant correlation was found
between hormone sensitivity in vitro and
patient response to endocrine therapy
(Table VI, 2x = 0-05, Fisher's exact test).
No correlation was found between response
and disease-free interval (Table V). The
median disease-free interval in responders
was 27-5 months (range 12-46) and in
non-responders 18 months (range 0-52).
DISCUSSION
Over the years a number ofpublications
have presented data in terms of in vitro
response to hormones and chemotherapy
ofhuman solid tumours. Different methods
have been applied, and advantages as well
as disadvantages in these methods have
been extensively discussed (Dendy, 1980;
Hodges, 1976; Lasfarques, 1975; Masters
et al., 1980) and will not be discussed
further in the present paper.
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TABLE V.-Hormonal sensitivity of human breast-cancer tissue in vitro and patients'
response to endocrine therapy
Disease- Metastatic sites
free I A__ _
interval Soft
(months) tissue
15
15
39 +
16
5 +
46 +
43
52 +
31
12 +
38
43
3
18
24
34
22
8
12
+
+
+
Bone
+
In vitro [3H]dT activity
at min/,ug protein (s.d.)
Lung Liver Control Oestrogen Tes
+
+ +
+
+ 632 (50)
+ 660 (51)
675 (52)
235 (63)
91 (25)
57 (20)
360 (75)
+ 1090 (371)
+ 254 (57)
+ 524 (97)
251 (31)
291 (103)
412 (38)
172 (46)
146 (30)
123 (14)
+ 177 (72)
+ + 323 (40)
+ 125 (27)
20 10 + +
49
3
0
+ +
977 (29*)
356 (87)*
665 (116)
523 (77)*
107 (20)
91 (13)*
135 (111)*
1545 (340)
187 (26)
419 (125)
315 (11)*
254 (68)
365 (33)
227 (48)
172 (43)
101 (16)
151 (55)
338 (39)
217 (33)*
175 (62) 159 (72)
198 (130)
118 (36)
129 (72)
137 (87)
226 (27)*
106 (41)
CR: Complete remission.
PR: Partial remission.
SD: Stationary disease.
PD: Progressive disease.
* Significant difference from control cultures (P < 0 05).
Treatment
3tosterone Type Response
642 (74) Diethylstilboestrol PD
625 (65) Castration PR
612 (87) Tamoxifen PR
322 (56)* Prednisone PR
79 (39) Tamoxifen PD
Diethylstilboestrol CR
135 (43)* Tamoxifen PR
1276 (335) Tamoxifen PD
206 (33) Prednisone PD
399 (93)* Castration, PD
Testosterone
228 (28) Tamoxifen PD
258 (38) Tamoxifen PD
- Prednisone PD
Castration PD
173 (45) Castration, SD
Tamoxifen
Tamoxifen SD
- Castration PD
333 (36) Castration PD
117 (23) Castration, CR
Tamoxifen
Castration, PD
Tamoxifen
141 (59) Tamoxifen SD
193 (46)* Diethylstilboestrol PD
104 (24) Castration, PD
Prednisone
TABLE VI.-Hormonal sensitivity of human breast-cancer tissue in vitro and patients
response to endocrine therapy
Hormone-sensitive
Hormone-insensitive
* Symbols as in Table V.
CR+PR SD+PD
l
1
4
13
Statistical evaluation
(Fisher's exact test)
2a = 0 05 Just significant
However, it was observed that breast-
cancer tissue shows varying [3H]-dT up-
take during the first 48 h of cultivation,
and that the hormonal effect could be
recorded as both an increase and decrease
in the same tumour at varying times after
hormone exposure. This observation is
new and, was not caused by uncontrolled
methodological factors. Incorporation of
[3H]-dT into acid-insoluble material is a
common method of estimating DNA
synthesis. A number of unknown factors
influences the incorporation of this tracer,
and complicates the interpretation ofdata
obtained with this compound. It has
been generally accepted in a number of
papers that the rate of DNA synthesis
may be correlated with the rate of cell
proliferation (Aspegren & Danielsson,
1974; Finkelstein et al., 1975; Lippman &
Bolan, 1975; Lippman et al., 1975;
Pasteels et al., 1976). If this were so, the
Pt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
21
22
23
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observed variation in [3H]-dT uptake
could reflect cohorts of cycling syn-
chronous cells entering and leaving S.
The hormonal effect might then in some
tumours be an acceleration or deceleration
of the pool of synchronized cells around
the S phase. This could explain why
Aspegren & Danielsson (1974) observed
that cells continuously labelled with
[3H]-dT for 24 h took up only twice as
much label as those labelled for 4h. If the
cells pass or enter the S phase synchron-
ously, it is likely that, in a period, no cells
are in S and therefore none label.
But the data can be interpreted in a
totally different way. If the endogenous
pool of dT varies with time, or if a
hormonal exposure of the cultures de-
creases or increases the endogenous pool
of dT, this could lead to varying ratios of
[3H]-dT to dT incorporated into DNA, and
fluctuation in this ratio could be respon-
sible for the variation in radioactivity
recorded in the acid-insoluble material
(Lippman & Aitken, 1980). That this
phenomenon does occur has been proved
by Lippman & Aitken, who observed the
paradoxical fact that [3H]-dT in acid-
insoluble material ofMCF-7 human breast-
cancer cell lines was increased by adding
tamoxifen, a well known anti-oestrogen
which decreases cell proliferation. Their
data indicated that tamoxifen administra-
tion drastically reduces the endogenous
dT pool and caused a nearly complete
dependence on exogenous dT for DNA
synthesis. Whatever the interpretation
might be, it is clear that hormones in
some tumours have an effect on dT
incorporation into DNA. It is also clear
from the present investigation that this
effect can be recorded after 24 h hormone
exposure, which is in agreement with
others (Aspegren, 1974; Aspegren & Dan-
ielsson, 1974; Burstein & Carey, 1974;
Lippman et al., 1975; Lippman & Bolan,
1975). Whether the optimal time to test
the dT uptake is > 24 h after explantation
is not possible to conclude from the
present study. Other tumours might
possibly have shown hormonal sensitivity
in vitro at other times. However, whenever
a significant difference in dT uptake was
seen in hormone-treated cultures, com-
pared to controls, in the 7 tumours tested
at different times, it was consistently
recorded after 24 h of culture.
Though the number of patients is
limited in this study, and the trial was
retrospective, the observed significant
correlation between the response to hor-
monal treatment in patients with ad-
vanced breast cancer and the in vitro
hormonal sensitivity of the corresponding
tumours is of interest. It should be
emphasized, however, that only half of
the patientswho wereexpected to respond
on the basis of the in vitro test actually
responded to endocrine therapy. On the
other hand, only one patient responded to
endocrine therapy in the in vitro hormone-
insensitive group. Thus this study agrees
with the results of Burstein & Carey
(1974), who found that 17/23 patients
with advanced breast cancer correlated
with the hormonal response in vitro. Our
study is also consistent with another
study (Dendy, 1980) in which in vitro
methods were helpful in selecting patients
who were chemotherapy-resistant.
One other group (Flax et al., 1973; Salih,
1972) has previously published that the
influence of hormones in vitro on breast-
cancer tissue, as measured by influence
on glucose-6-phosphate dehydrogenase ac-
tivity, was correlated with the clinical
response in patients with advanced breast
cancer. However, it should be pointed out
that their method has never been repro-
duced (Masters et al., 1977).
In conclusion the present test does, to
some extent, reflect the in vivo hormonal
dependence of some breast tumours. The
test, however, cannot be used alone to
predict patients' response to hormonal
therapy, but it is possible that this test,
in combination with steroid-receptor de-
terminations, could more precisely predict
which patients with advanced breast
cancer might benefit from hormonal
treatment. This remains to be shown in a
prospective controlled trial.
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